drugset / Trial / NCT04499976

Isonicotinic Acid Hydrazide Pretreatment With Misoprostol Induction of Abortion in First-trimester Missed Miscarriage

NCT04499976

Phase 4 Unknown 240 enrolled Aswan University Hospital
RandomizedParallel-groupQuadruple-blindTreatment

Summary

This study compares the success rate of Adjuvant isonicotinic acid hydrazide and misoprostol versus misoprostol alone for medical termination of first-trimester pregnancy among women with one or more previous cesarean deliveries.

Timeline

Start
2020-09-01
Primary completion
2021-04-30
Completion
2021-06-30

Drugs

EvaluationDrugModalityDoseRoute
Subject Isonicotinic Acid Hydrazide Unknown 900 mg
Background Misoprostol Other / unclassified 800 ug Intravenous

Indications

No indication recorded.